| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.14 | 0.4 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.023 | 0.4 |